Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
ZNF674 was first implicated in X-linked intellectual disability in a single pedigree presenting with cognitive impairment, short stature (HP:0004322), and retinal dystrophy (HP:0000556). A nonsense variant, c.337G>T (p.Glu113Ter), predicted to truncate all zinc-finger domains, was identified in one of 28 linked families (PMID:16385466). Sequencing of 306 additional XLID patients revealed only missense changes of uncertain significance without further segregation. Importantly, reanalysis of 10,563 control X chromosomes found the same truncating c.337G>T variant at appreciable frequency, challenging its pathogenicity (PMID:23871722). Functional support is limited to in silico modeling predicting reduced DNA binding. Overall, the genetic and experimental data are conflicting and insufficient, supporting a disputed classification for ZNF674 in XLID. Key Take-home: ZNF674 should not be routinely included in XLID diagnostic panels without additional corroborative evidence.
Gene–Disease AssociationDisputedSingle family with c.337G>T (p.Glu113Ter) in ZNF674 ([PMID:16385466]); same truncating variant found in controls ([PMID:23871722]) Genetic EvidenceLimitedOne truncating variant in a single pedigree; no additional probands or segregation; variant present in population controls Functional EvidenceLimitedEvidence restricted to in silico modeling of DNA-binding impairment without cellular or animal validation |